Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001209191-12-037740
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-07-10 14:11:29
Reporting Period:
2012-07-06
Filing Date:
2012-07-10
Accepted Time:
2012-07-10 14:11:29
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1339455 Somaxon Pharmaceuticals Inc. SOMX Pharmaceutical Preparations (2834) 200161599
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1173408 L.p. Iii Bioventures Mpm C/o Mpm Asset Management
200 Clarendon Street, 54Th Floor
Boston MA 02116
No No Yes No
1173409 L.p. Iii-Qp Bioventures Mpm C/o Mpm Asset Management
200 Clarendon Street, 54Th Floor
Boston MA 02116
No No Yes No
1249063 Mpm Bioventures Iii Parallel Fund, L.p. C/o Mpm Asset Management
200 Clarendon Street, 54Th Floor
Boston MA 02116
No No Yes No
1249133 Mpm Bioventures Iii Gmbh & Co. Beteiligungs Kg C/o Mpm Asset Management
200 Clarendon Street, 54Th Floor
Boston MA 02116
No No Yes No
1249143 L.p. Gp Iii Bioventures Mpm C/o Mpm Asset Management
200 Clarendon Street, 54Th Floor
Boston MA 02116
No No Yes No
1249147 Mpm Bioventures Iii Llc C/o Mpm Asset Management
200 Clarendon Street, 54Th Floor
Boston MA 02116
No No Yes No
1346986 Mpm Asset Management Investors 2005 Bviii Llc C/o Mpm Asset Management
200 Clarendon Street, 54Th Floor
Boston MA 02116
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2012-07-06 671,217 $0.29 2,900,460 No 4 S Indirect See Footnote
Common Stock Disposition 2012-07-09 1,624,574 $0.31 1,275,886 No 4 S Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
Footnotes
  1. The shares were sold as follows: 559,506 by MPM BioVentures III-QP, L.P. ("BV III QP"), 37,622 by MPM BioVentures III, L.P. ("BV III"), 9,907 by MPM Asset Management Investors 2005 BVIII LLC ("AM 2005"), 16,901 by MPM BioVentures III Parallel Fund, L.P. ("BV Parallel") and 47,281 by MPM BioVentures III GmbH & Co. Beteiligungs KG ("BV KG"). MPM BioVentures III GP, L.P. ("MPM III GP") and MPM BioVentures III LLC ("MPM III LLC") are the direct and indirect general partners of BV III QP, BV III, BV Parallel and BV KG. Luke Evnin, Ansbert Gadicke, Nicholas Galakatos, Dennis Henner, Nicholas Simon III, Michael Steinmetz and Kurt Wheeler are the Series A members of MPM III LLC and the managers of AM 2005.
  2. The shares are held as follows: 2,417,716 by BV III QP, 162,570 by BV III, 42,835 by AM 2005, 73,032 by BV Parallel and 204,307 by BV KG. Each Reporting Person disclaims beneficial ownership of the securities except to the extent of his or its respective pecuniary interest therein.
  3. The shares were sold as follows: 1,354,196 by BV III QP, 91,057 by BV III, 23,979 by AM 2005, 40,907 by BV Parallel and 114,435 by BV KG.
  4. The shares are held as follows: 1,063,520 by BV III QP, 71,513 by BV III, 18,856 by AM 2005, 32,125 by BV Parallel and 89,872 by BV KG. Each Reporting Person disclaims beneficial ownership of the securities except to the extent of his or its respective pecuniary interest therein.